Bremelanotide
Also known as: PT-141, Bremelanotide Acetate, Bremelanotide Injection, Bremelanotide for Intranasal Use, Melanotan 2
Bremelanotide is a medication specifically designed to address hypoactive sexual desire disorder (HSDD), primarily affecting women. HSDD is characterized by a persistent lack of interest in sexual activity, significantly impacting personal relationships and overall life satisfaction. Approved by the FDA in 2019 under the brand name Vyleesi, Bremelanotide offers a novel approach for those whose previous treatments for HSDD have not been effective or suitable. Administered through injection, Bremelanotide acts on the brain's pathways by stimulating certain receptors that increase the release of ...
Potential Side Effects
Side effects score: 6; Bremelanotide can cause several side effects, with the most common being nausea, vomiting, headache, and injection site reactions. Users might also experience flushing, increased blood pressure, and facial flushing. Additionally, the supplement could lead to increased libido and hyperpigmentation, especially in areas where it is injected.
Health Categories
View efficacy ratings for Bremelanotide across multiple health categories.
Research & Evidence
Our efficacy ratings are based on scientific research and clinical studies.
Related Supplements
Supplements commonly explored alongside Bremelanotide
